4 In-Demand September Reports on Medical Diagnostics Market
28 Sep 2021 • by Natalie Aster
LONDON – Market Publishers is happy to announce that a lot of new in-demand studies prepared by our research partners have been added to our Diseases & Diagnostics catalogue in September. Our experts have prepared a selection of the 4 best-selling September reports featuring the medical diagnostics market available at MarketPublishers.com:
The global molecular diagnostics market is slated for healthy growth at a 2.98% CAGR between 2021 and 2026 to exceed USD 80.4 billion in value terms by the year 2026. The increasing geriatric population and rising incidence of infectious diseases including COVID-19 are poised to act as the major market growth engines. Furthermore, the market growth is also encouraged by large outbreaks of bacterial and viral epidemics in the world, mounting demand for Point-of-Care (PoC) diagnostics, remarkable advancements in pharmacogenomics, and rapidly evolving technologies in the field of genetic research and engineering. Additionally, the favourable government support in most countries also acts as a significant market growth driver. Among different technologies, polymerase chain reaction (PCR) is anticipated to grab the largest market share in the next five years…
The mammography market is poised to reach USD 3.8 billion in value term by the year 2028, registering growth at a 10% CAGR in the next 7 years. The rising number of initiatives by various governments and NGOs to raise awareness about the early diagnosis of microcalcifications in breast tissues is set to act as the key market growth engine. The major mammography manufacturers are anticipated to introduce new products, which is further expected to impel the demand in the coming years. Asia-Pacific and Latin America are predicted to be the fastest-growing regional mammography markets, given the higher mammary gland cancer prevalence and the growing number of government campaigns to improve screening results in the region…
The global allergy diagnostics market is forecast to demonstrate growth at a CAGR of 11.1% between 2021 and 2026, fueled by such factors as the increasing incidence of allergic diseases and associated heavy economical burden, rising environmental pollution levels, growing investments in allergy diagnostics, and the increasing access to healthcare insurance. Additionally, the increasing use of mHealth in allergy diagnosis is anticipated to open new growth opportunities for the allergy diagnostics market during the forecast period. In vivo tests are expected to hold the largest share of the allergy diagnostics market (by test type) during the forecast period. Geographically, North America is poised to dominate the global allergy diagnostics market in the next 5 years…
In-Vitro Diagnostics (IVD) Market
The world’s in-vitro diagnostics (IVD) market is supposed to increase at a low single-digit CAGR from 2021 to 2028 and is poised to go beyond USD 96.4 billion in value terms by 2028. Such factors as the rising incidence of chronic and infectious diseases, expanding adoption of point-of-care testing, the introduction of next-generation molecular diagnostics along with minimally invasive and non-invasive in-vitro diagnostics, and the growing number of CLIA-waived tests are expected to act as the major market growth engines through 2028. However, the rising number of product recalls, lack of skilled laboratory technicians in developing nations, inadequate reimbursements, and stringent regulatory framework may hamper the market growth to some extent…
Many other insightful research studies covering the medical diagnostics markets can be found in this Market Publishers’ catalogue.
Analytics & News
